Follow
Satyananda Patel
Satyananda Patel
Postdoc, CHN-US Hormel Cancer Institute, Zhengzhou, Henan, China
Verified email at hci-cn.org
Title
Cited by
Cited by
Year
Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation
S Patel, S Kumar, A Jyoti, BS Srinag, RS Keshari, R Saluja, A Verma, ...
Nitric Oxide 22 (3), 226-234, 2010
1802010
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
Xueli Tian, Tingxuan Gu, Satyananda Patel, Ann M. Bode, Mee-Hyun Lee, Zigang ...
npj Precision Oncology 3, 2019
1022019
Nitric oxide synthase localization in the rat neutrophils: immunocytochemical, molecular, and biochemical studies
R Saini, S Patel, R Saluja, AA Sahasrabuddhe, MP Singh, S Habib, ...
Journal of leukocyte biology 79 (3), 519-528, 2006
962006
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model.
LF Zhang Y, Patel S, Abdelouahab H, Wittner M, Willekens C, Shen S, Betems A ...
Cell Death Dis. 3, 2012
752012
Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rγ−/− mice
S Patel, Y Zhang, B Cassinat, F Zassadowski, N Ferre, W Cuccuini, ...
Leukemia 26 (11), 2432-2435, 2012
302012
Nitric oxide‐mediated augmentation of neutrophil reactive oxygen and nitrogen species formation: Critical use of probes
S Kumar, S Patel, A Jyoti, RS Keshari, A Verma, MK Barthwal, M Dikshit
Cytometry Part A 77 (11), 1038-1048, 2010
292010
Ion channel modulators mediated alterations in NO-induced free radical generation and neutrophil membrane potential
S Patel, J Vemula, S Konikkat, MK Barthwal, M Dikshit
Free radical research 43 (5), 514-521, 2009
192009
Protein kinase B (AKT) mediates phospholipase D activation via ERK1/2 and promotes respiratory burst parameters in formylpeptide-stimulated neutrophil-like HL-60 cells
S Patel, B Djerdjouri, Y Raoul-Des-Essarts, PMC Dang, J El-Benna, ...
Journal of Biological Chemistry 285 (42), 32055-32063, 2010
172010
Activation of inflammatory response and apoptosis of polymorphonuclear leukocytes in patients with argemone oil poisoning
CK Babu, KM Ansari, S Mehrotra, S Patel, M Dikshit, M Das
Chemico-biological interactions 183 (1), 154-164, 2010
122010
BCL-2 inhibitor ABT-737 effectively targets leukemia-initiating cells with differential regulation of relevant genes leading to extended survival in a NRAS/BCL-2 mouse model of …
International Journal of Molecular Sciences, 2021
92021
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies
C Le Pogam, S Patel, P Gorombei, L Guerenne, P Krief, N Omidvar, ...
Oncotarget 6 (32), 32494, 2015
52015
PHLDA1 promotes glioblastoma cell growth via sustaining the activation state of Ras
J Wang, N Yao, Y Hu, M Lei, M Wang, L Yang, S Patel, X Li, K Liu, Z Dong
Cellular and Molecular Life Sciences 79 (10), 1-17, 2022
42022
Neutrophil extracellular trap formation by nitric oxide donors: involvement of nitric oxide synthase and myeloperoxidase derived free radicals
S Patel, S Kumar, R Saluja, MK Barthwal, K Mitra, A Verma, VK Bajpai, ...
The FASEB Journal 22, 1072.9-1072.9, 2008
32008
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic …
S Patel, L Guerenne, P Gorombei, N Omidvar, MH Schlageter, AA Alex, ...
Blood cancer journal 5 (12), e374-e374, 2015
12015
Role of p38 MAPK in PMA‐induced NETs release from human neutrophils
RS Keshari, S Kumar, A Jyoti, S Patel, MK Barthwal, A Verma, VK Bajpai, ...
The FASEB Journal 24, 984.19-984.19, 2010
12010
Nitric oxide dependent increase in free radical generation mediates release of extracellular traps from human neutrophils
A Jyoti, RS Keshari, S Kumar, S Patel, BS Srinag, A Verma, MK Barthwal, ...
The FASEB Journal 23, 890.10-890.10, 2009
12009
Establishment of Acute myeloid leukemic xenografts as preclinical models of epigenetic therapies
Satyananda Patel,Yanyan Zhang, Audrey Cras, Mallorie Mangean- Dépond, Fabien ...
International Journal of Hematology Research 1 (3), 2015
2015
pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid (ATO+ATRA) targeted therapy effectively increases survival of APL mice
Satyananda Patel, Laura Guerenne, Petra Gorombei, Nader Omidvar, Marie ...
Blood Cancer Journal, 2015
2015
International Journal of Hematology Research
S Patel, Y Zhang, A Cras, M Mangean-Dépond, F Zassadowski, V Maud, ...
2015
175 ADJUVANT, PVAX14 DNA, AS AN IMMUNOTHERAPY FOR A MOUSE MODEL OF HIGH RISK MYELODYSPLASTIC SYNDROME (HR-MDS) EXTENDS SURVIVAL AS ADD-ON TREATMENT TO AZACITIDINE (AZA)
RA Padua, P Gorombei, C Le Pogam, S Patel, L Guerenne, N Omidvar, ...
Leukemia Research, S88-S89, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20